Accessibility
· 13 checks — Landmarks, headings, alt text, forms, and link quality rolled into one auditable list.DLink & Button QualityAction3 issue(s) across 357 links and 22 buttonsFIX
| Element | Text | Issue | Suggested Fix |
|---|---|---|---|
| /stat-mini-crossword/ | Test your knowledge with our n… | img no alt | Add alt attribute to the image |
| https://www.statnews.com/2026/04/07/stat… | (empty) | empty | Add link text or aria-label |
| https://www.statnews.com/2026/04/07/stat… | (empty) | empty | Add link text or aria-label |
| https://www.statnews.com/2026/04/07/stat… | Learn More | generic text | Replace with descriptive text |
Before: Learn More Suggested: Stat Madness 2026 Winner Uncovered Driving Force Abdominal Aortic Aneurysms | |||
| /stat-plus/ | STAT+ | img no alt | Add alt attribute to the image |
| https://reports.statnews.com/ | All Reports | new tab | Add '(opens in new tab)' to text |
| https://reports.statnews.com/ | All Reports | new tab | Add '(opens in new tab)' to text |
| https://reports.statnews.com/products/in… | Chaotic and politicized: Insid… | new tab | Add '(opens in new tab)' to text |
| https://reports.statnews.com/products/am… | American Science, Shattered | new tab | Add '(opens in new tab)' to text |
| https://reports.statnews.com/products/bi… | 2025 Edition: Ranking Biotech'… | new tab | Add '(opens in new tab)' to text |
| /category/readout-loud/ | The Readout LOUD Ou… | img no alt | Add alt attribute to the image |
| /category/first-opinion-podcast/ | First Opinion Podcast … | img no alt | Add alt attribute to the image |
| /category/color-code/ | Color Code Enjoy th… | img no alt | Add alt attribute to the image |
| https://reports.statnews.com/ | Download our latest Report | new tab | Add '(opens in new tab)' to text |
| https://flipboard.com/@STATnews | new tab | Add '(opens in new tab)' to text | |
| https://x.com/statnews/ | X | new tab | Add '(opens in new tab)' to text |
| https://www.linkedin.com/company/stat-ne… | new tab | Add '(opens in new tab)' to text | |
| https://www.facebook.com/statnews/ | new tab | Add '(opens in new tab)' to text | |
| https://www.youtube.com/channel/UC89FjSf… | Youtube | new tab | Add '(opens in new tab)' to text |
| https://www.instagram.com/statnews/ | new tab | Add '(opens in new tab)' to text | |
| https://www.threads.com/@statnews/ | Threads | new tab | Add '(opens in new tab)' to text |
Links without text are announced as raw URLs by screen readers.
https://www.statnews.com/2026/04/07/stat-madness-2026-winner-uncovered-drivin…; https://www.statnews.com/2026/04/07/stat-madness-2026-winner-uncovered-drivin…
Links with no accessible text (empty <a></a>, image-only no alt, icon-only no aria-label) are unidentifiable to screen readers.
Source: WCAG 2.1 SC 2.4.4
Generic link text like 'click here' doesn't describe the destination.
https://www.statnews.com/2026/04/07/stat-madness-2026-winner-uncovered-drivin… ("Learn More")
Generic anchor text ('click here', 'read more', 'learn more') tells screen readers and search engines nothing about the destination.
Learn more ▾ ▴
Out-of-context lists of links read by AT (one navigation pattern) become useless when every link says 'click here'. Use the destination's title or topic as anchor text. Doubles as SEO win — Google passes anchor-text relevance to the destination.
Source: WCAG 2.4.4 / Google Search Central
Image-only links need alt text on the image (or aria-label on the link) so screen readers can announce them.
a[href="/stat-mini-crossword/"]; a[href="/stat-plus/"]; a[href="/category/readout-loud/"]; a[href="/category/first-opinion-podcast/"]; a[href="/category/color-code/"]
Image-only links with no alt are unidentifiable to screen-reader users — link's destination is invisible.
Source: WCAG 2.1 SC 2.4.4
Add '(opens in new tab)' to link text or aria-label.
https://reports.statnews.com/; https://reports.statnews.com/; https://reports.statnews.com/products/inside-the-fda-under-trump; https://reports.statnews.com/products/american-science-shattered; https://reports.statnews.com/products/biotech-top-venture-capital-firms-2025; https://reports.statnews.com/; https://flipboard.com/@STATnews; https://x.com/statnews/; https://www.linkedin.com/company/stat-news/; https://www.facebook.com/statnews/ (+3 more)
Links with target="_blank" without rel="noopener" leak the originating page's window context — security and UX issue.
Learn more ▾ ▴
Without rel="noopener", the new tab can navigate the original tab via window.opener (tab-nabbing attack). Modern browsers default to noopener for target=_blank but only since recent versions. Always set rel="noopener noreferrer" explicitly.
Source: MDN target / OWASP
DDark Mode SupportActionNo dark mode signalsFIX
Detection limited to meta tags and inline styles.
BFavicon & Branding6 icon(s) detectedREVIEW
CWeb ManifestActionValid manifestREVIEW
A+Landmark Structure66 landmarksPASS
A+Heading Hierarchy152 headingsPASS
- H1 STAT — A decade of reporting from the frontiers of health and medicine
- H2 Latest
- H3 Flu vaccine no longer mandated for U.S. troops, defense secretary says
- H3 STAT Plus: RFK Jr. to face four GOP doctors at Senate hearings
- H3 STAT Plus: I’m an expert on presidential health. The 25th Amendment is not an option for removing Trump
- H3 Judge postpones OxyContin-maker Purdue Pharma’s sentencing to let opioid victims attend in person
- H3 STAT Plus: CMS to ask every state for new audits of health care providers
- H3 The U.S. health care system is built around looking backward
- H2 Play
- H2 Don't Miss
- H2 Top Stories
- H3 STAT Plus: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS
- H3 STAT Plus: UnitedHealth earnings beat expectations in the first quarter, but hurdles persist
- H3 STAT Plus: BioAge says experimental pill aimed at reducing heart risks significantly reduced inflammation
- H3 STAT Plus: Tortugas Neuroscience launches with hopes to develop drugs for brain disorders, other conditions
- H3 STAT Plus: Trump’s plan to give seniors cheaper obesity drugs in Medicare hits a snag
- H3 STAT Plus: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride
- H2 Most Read
- H3 The U.S. health care system is built around looking backward
- H3 What happens when a chief executive loses executive functions?
- H3 The contradiction at the heart of Republicans’ embrace of psychedelics
- H3 A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career
- H3 Medical schools must continue to teach students about structural barriers to care
- H2 Most Read In STAT+
- H3 STAT Plus: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride
- H3 STAT Plus: PBMs warn Trump’s proposal to disclose drug prices is illegal
- H3 STAT Plus: Kennedy hints at coming breakthrough device announcement
- H3 STAT Plus: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
- H3 STAT Plus: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
- H2 Sponsored
- H2 Newsletters
- H3 STAT Plus: RFK Jr. to face four GOP doctors at Senate hearings
- H3 STAT Plus: Kelonia Therapeutics’ road from floundering to $3 billion
- H3 STAT Plus: Pharmalittle: We’re reading about a Purdue Pharma settlement, a setback for Merck and Eisai, and more
- H2 STAT+
- H3 Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.
- H2 Trending Now
- H3 STAT Plus: PBMs warn Trump’s proposal to disclose drug prices is illegal
- H3 STAT Plus: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
- H3 STAT Plus: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
- H3 STAT Plus: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride
- H3 STAT Plus: Extended use of Nektar Therapeutics drug shows promise in alopecia
- H2 Events
- H3 STAT@AACR: Outsmarting Cancer
- H3 AACR 2026: The STAT Recap
- H3 2026 Breakthrough Summit West
- H3 STAT@ASCO: Science vs. Cancer
- H2 Trackers
- H3 Obesity Drug Tracker
- H3 CRISPR Tracker
- H3 Generative AI Tracker
- H3 Breakthrough Device Tracker
- H2 Reports
- H3 Chaotic and politicized: Inside the FDA under Trump
- H2 American Science, Shattered
- H2 2025 Edition: Ranking Biotech's Top Venture Capital Firms
- H2 Podcasts
- H2 The Readout LOUD
- H2 First Opinion Podcast
- H2 Color Code
- H2 More Stories
- H3 Flu vaccine no longer mandated for U.S. troops, defense secretary says
- H3 STAT Plus: RFK Jr. to face four GOP doctors at Senate hearings
- H3 STAT Plus: I’m an expert on presidential health. The 25th Amendment is not an option for removing Trump
- H3 Judge postpones OxyContin-maker Purdue Pharma’s sentencing to let opioid victims attend in person
- H3 STAT Plus: CMS to ask every state for new audits of health care providers
- H3 The U.S. health care system is built around looking backward
- H3 What happens when a chief executive loses executive functions?
- H3 STAT Plus: At AACR, a provocative use of CAR-T, Merck’s new thing and cancer’s geography problem
- H3 STAT Plus: Former banker brought on to revitalize Pfizer’s strategy departs his post
- H3 STAT Plus: In early trial, CAR-T results raise hope of preventing multiple myeloma in high-risk patients
- H3 STAT Plus: Trump order to advance psychedelic treatments generates excitement — and worries
- H3 The contradiction at the heart of Republicans’ embrace of psychedelics
- H3 STAT Plus: CMS to ask every state for new audits of health care providers
- H3 STAT Plus: Trump’s plan to give seniors cheaper obesity drugs in Medicare hits a snag
- H3 STAT Plus: I’m an expert on presidential health. The 25th Amendment is not an option for removing Trump
- H3 STAT Plus: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS
- H3 STAT Plus: UnitedHealth earnings beat expectations in the first quarter, but hurdles persist
- H3 A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
- H3 STAT Plus: Kelonia Therapeutics’ road from floundering to $3 billion
- H3 STAT Plus: Pharmalittle: We’re reading about a Purdue Pharma settlement, a setback for Merck and Eisai, and more
- H3 STAT Plus: Kennedy hints at coming breakthrough device announcement
- H3 STAT Plus: The PBMs fight back, and arbitration doesn’t lose
- H3 STAT Plus: Finally cracking KRAS as a druggable target
- H3 STAT Plus: Pharmalittle: We’re reading about Trump boosting psychedelic treatment, the future for weight-loss drugs, and more
- H3 STAT Plus: I’m an expert on presidential health. The 25th Amendment is not an option for removing Trump
- H3 The U.S. health care system is built around looking backward
- H3 What happens when a chief executive loses executive functions?
- H3 The contradiction at the heart of Republicans’ embrace of psychedelics
- H3 Measles outbreak means my immunocompromised son can’t leave the house without extreme safety measures
- H3 Politicians are using low teen birth rates to further restrict access to birth control, abortion
- H2 Newsletters
- H2 Our Picks
- H3 STAT Plus: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
- H3 STAT Plus: Hospitals roll out chatbots, looking to reclaim their role in patients’ health conversations
- H3 STAT Plus: Flawed study on the antidepressant Paxil came with a cautionary note — if you knew how to find it
- H3 STAT Plus: AI could check millions of CT scans for heart risk. Who will pay for it?
- H3 A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career
- H3 STAT Plus: A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope
- H3 What the peptide craze reveals about Americans’ relationship with risk
- H3 STAT Plus: UnitedHealth Group is making a $3 billion bet on AI. What does it mean for patients?
- H2 Biotech
- H3 STAT Plus: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
- H3 STAT Plus: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
- H3 STAT Plus: Roche to launch another Elevidys trial, with eyes on European approval
- H3 STAT Plus: New Bain biotech startup, building on BMS drugs, gets a name and a CEO
- H2 Pharma
- H3 STAT Plus: A controversy over research monkeys highlights ambiguity over health standards
- H3 STAT Plus: A controversy over research monkeys highlights ambiguity over health standards
- H3 STAT Plus: Up and down the ladder: The latest comings and goings
- H3 STAT Plus: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
- H2 Health
- H3 Even for trans adults, care is hard to find: ‘I could not do it on my own’
- H3 Even for trans adults, care is hard to find: ‘I could not do it on my own’
- H3 STAT Plus: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows
- H3 Trump taps former public health leader Erica Schwartz to run CDC
- H2 Politics
- H3 How Trump is pushing psychedelics reform through the health agencies
- H3 How Trump is pushing psychedelics reform through the health agencies
- H3 Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role
- H3 STAT Plus: Kennedy focuses on affordability, combating fraud in Capitol Hill hearings
- H2 Video
- H3 How sports betting apps hook users
- H3 STAT reporter goes up against radiologists to spot deepfake X-rays
- H3 Health influencers talk social media and mental health
- H3 STAT Plus: Inside the delicate, high-stakes search for a new CDC director
- H2 Health tech
- H3 STAT Plus: CMS proposes rolling back breakthrough device payment flexibilities
- H3 STAT Plus: CMS proposes rolling back breakthrough device payment flexibilities
- H3 STAT Plus: Access granted: CMS greenlights more than 150 participants for chronic care experiment
- H3 STAT Plus: Top health officials highlight efforts to make medical records more portable
- H2 In the Lab
- H3 Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests
- H3 Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests
- H3 What growing up in an end-times church taught a science communicator about dispelling misinformation
- H3 NIH grant terminations affected women scientists more than men, study finds
- H2 Hospitals
- H3 STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital
- H3 STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital
- H3 STAT Plus: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality
- H3 STAT Plus: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again
- H2 Insurance
- H3 STAT Plus: Medicare Advantage growth dwindles for a second straight year
- H3 STAT Plus: Medicare Advantage growth dwindles for a second straight year
- H3 STAT Plus: Federal government turns to fresher data to rein in Medicare Advantage upcoding
- H3 STAT Plus: UnitedHealth has turned Medicare Advantage coding into ‘profit-centered strategy,’ Senate report finds
- H2 Podcasts
- H3 A new trick for old science, and biotech VCs’ scrambled playbook
- H3 How sports betting is hooking some young men
- H3 Biotech investors’ plea to Trump, and a busy M&A week
- H3 Eli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy
- H2 Sign up for our Morning Rounds newsletter
A+Alt Text QualityAll 189 images OKPASS
AForm Accessibility1 of 4 controls have issuesPASS
| Control | Type | Label | Method |
|---|---|---|---|
| s | search | Search … | aria-label |
| Enter your email | aria-label | ||
| #newsletter-email | Enter your email address | for/id | |
| input | submit | (none) | none |
Form controls need a <label>, aria-label, or aria-labelledby for screen readers.
<input type="submit">
Form controls without labels — assistive tech announces 'edit text' with no context; users can't complete forms.
Source: WCAG 2.1 SC 3.3.2
A404 Error PageHTTP 404, custom pagePASS
A+Print StylesheetPrint styles detectedPASS
A+Color Contrast (Screenshot)20 text elements analyzed, 0 fail WCAG AAPASS
Analyzes text contrast against the actual rendered page, including background images, gradients, and overlays that CSS-based tools cannot detect.
Show all checked elements (20)
| Element | Ratio | Required | FG | BG | Result |
|---|---|---|---|---|---|
| h1 STAT — A decade of… | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Play | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Don't Miss | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Top Stories | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Most Read | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Sponsored | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Trending Now | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Events | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Trackers | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Reports | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Podcasts | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 The Readout LOUD | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 First Opinion Podcas… | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Color Code | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 More Stories | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Our Picks | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h2 Sign up for our Morn… | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| h3 Your go-to source fo… | 21.00:1 | 3.0:1 | #000000 | #FFFFFF | Pass |
| title STAT | A decade of r… | 21.00:1 | 4.5:1 | #000000 | #FFFFFF | Pass |
| a Skip to Main Content | 21.00:1 | 4.5:1 | #000000 | #FFFFFF | Pass |
Methodology: The top 20 text elements by font size were checked. Background color was sampled from the desktop screenshot using a 5-point pattern. WCAG 2.1 AA requires 4.5:1 for normal text and 3:1 for large text.
A+Lighthouse Accessibility AuditsScore 97/100 — 1 failing, 30 passedPASS
Accessibility
These checks highlight opportunities to improve the accessibility of your web app. Automatic detection can only detect a subset of issues and does not guarantee the accessibility of your web app, so manual testing is also encouraged.
Tables and lists
Screen readers require list items (`<li>`) to be contained within a parent `<ul>`, `<ol>` or `<menu>` to be announced properly. Learn more about proper list structure.
Performance issues directly impact user engagement and conversion rates.
| Failing Elements |
|---|
About nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
Our Team nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
Contact Us nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
Careers nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
Diversity & Inclusion nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
Awards nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
Advertise With Us nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
STAT Brand Studio nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
Licensing Stories nav.footer-nav > div#ac-0 > ul#ac-panel-0 > li |
STAT+ nav.footer-nav > div#ac-1 > ul#ac-panel-1 > li |
STAT+ Discounts nav.footer-nav > div#ac-1 > ul#ac-panel-1 > li |
Group Subscriptions nav.footer-nav > div#ac-1 > ul#ac-panel-1 > li |
FAQ nav.footer-nav > div#ac-1 > ul#ac-panel-1 > li |
My Account nav.footer-nav > div#ac-1 > ul#ac-panel-1 > li |
Log In nav.footer-nav > div#ac-1 > ul#ac-panel-1 > li |
Subscribe nav.footer-nav > div#ac-1 > ul#ac-panel-1 > li |
Events nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
Newsletters nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
Reports nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
Podcasts nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
Mini Crossword nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
Community nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
Shop STAT nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
App nav.footer-nav > div#ac-2 > ul#ac-panel-2 > li |
These are opportunities to improve the experience of reading tabular or list data using assistive technology, like a screen reader.